|
Results of immunological evaluation* |
||
| Patient 1 |
Patient 2 |
|
|
|
||
| Age |
64 |
46 |
| WBC (cells/uL) |
8.3 (3.2–9.8) |
6.9 (5.0–10.2) |
| Granulocytes (%) |
59 (42–75) |
68 (45–75) |
| Lymphocytes (%) |
28 (20–51) |
18 (20–50) |
| Monocytes (%) |
9.5 (0–12) |
12 (0–8) |
| IgM (mg/dL) |
25 |
95 (50–300) |
| IgG (mg/dL) |
360 |
260 (565–1765) |
| IgA (mg/dL) |
27 |
16 (40–350) |
| C3 (mg/dL) |
ND |
129 (85–200) |
| C4 (mg/dL) |
ND |
23 (14–53) |
| CH50 (U/ml) |
ND |
51 (22–60) |
| CD4+ (cells/uL) |
1023 (720–1440) |
624 (575–1070) |
| CD8+ (cells/uL) |
979 (315–788) |
477 (190–860) |
| NK (cells/uL) |
ND |
135 (150–880) |
| CD19+ (cells/uL) |
0 (113–495) |
0 (70–300) |
| SPEP |
Hypogammaglobulinemia |
Hypogammaglobulinemia |
| Pneumococcal responses |
Impaired |
Impaired |
|
Abbreviations: SPEP, serum protein electrophoresis; WBC, white blood cells; NK, natural killer; * Values in parentheses represent reference ranges | ||
Sigmon et al. Clinical and Molecular Allergy 2008 6:5 doi:10.1186/1476-7961-6-5 |
||